Abstract presented at the European Breast Cancer Conference:
“The ALEXANDRA/IMpassion030 trial is the first study to look at the role of chemotherapy with or without atezolizumab post-surgery for early-stage triple-negative breast cancer.” – Dr. McArthur
Interviews with study author and breast cancer expert Heather McArthur, M.D. now available.
Please email for interviews, thank you.
